Triple Agonist Peptide for Advanced Metabolic Support

 Product Overview

Retatrutide is a next-generation GLP-1/GIP/Glucagon receptor agonist developed to powerfully target multiple metabolic pathways. This advanced peptide blend supports fat loss, appetite regulation, and improved glucose control—making it a premier option in the latest fat-loss research protocols.

 Key Benefits

 Appetite Regulation – Reduces cravings and supports calorie control
 Accelerated Fat Loss – Enhances energy expenditure and lipolysis
 Lean Muscle Preservation – Helps maintain muscle while reducing body fat
 Glucose & Insulin Balance – Promotes stable energy and improved metabolic health
 Enhanced Mitochondrial Function – Supports optimal cellular energy production
 Improved Sleep & Recovery – Indirect benefits through stabilized metabolism

 Product Details

• Form: 20mg lyophilized peptide vial
• Type: Injectable peptide (research use only)
• Storage: Keep refrigerated below 4°C
• Solvent: Bacteriostatic water recommended for reconstitution

 Recommended Peptide Stack

Enhance results with synergistic research compounds:

 Disclaimer

This product is sold for research and educational purposes only.
Not for human consumption, medical use, or diagnostic procedures.

 Combine for Maximum Synergy

 Retatrutide + MOTS-c → metabolic and mitochondrial boost
 Retatrutide + 5-Amino-1MQ → fat loss & energy synergy
 Retatrutide + Tesamorelin → visceral fat reduction and body recomposition.

 RETATRUTIDE 10MG – The Future of Metabolic Optimization
For advanced research into next-level fat loss, energy, and metabolic regulation.